Communication on COVID-19 Vaccination in Indonesia and the Truth of the Digital Society

Annisa Wahyuni Arsyad, Kheyene Molekandella Boer, Muhammad Noor

Abstract


COVID-19 vaccination during the pandemic appears and is considered an innovation or new thing that must be quickly implemented to minimize epidemic transmission. As a country affected by COVID-19, Indonesia has also started distributing vaccines to various parties. The distribution process encountered various challenges. One of them is the truth or public trust in the government regarding handling the COVID-19 outbreak, which affects people's decisions not to or to carry out vaccines. This paper uses a non-interactive qualitative method by collecting various information about COVID-19 vaccination from a communication perspective. The theory used is the diffusion of innovation to see how the people of Indonesia can accept vaccines amid many people's doubts about the government. Truth is an important concept that determines the success of the COVID-19 vaccine. However, there is much public apathy towards the government's work rhythm; on the other hand, the government continues to intensively socialize various ways related to the benefits of vaccines, safety, easy ways to get vaccines and other benefits. The government can achieve at least 70% of the Indonesian sub-population vaccination target by gaining trust.


Keywords


vaccines; covid-19; truth

Full Text:

PDF

References


Aida, Nur Rohmi. 2020. Akan Dimulai 2021, Ini Cara Masyarakat Mendapatkan Vaksin Covid-19. 28 Desember 2020. At https://kesehatan.kontan.co.id/news/akan-dimulai-tahun-2021-ini-cara-masyarakat-mendapatkan-vaksin-covid-19?page=2

BPMI Setpres. 2021. Presiden Jokowi Menerima Vaksin Covid-19 Perdana. 13 Januari 2021. At https://www.presidenri.go.id/siaran-pers/presiden-jokowi-menerima-vaksin-covid-19-perdana/

Devito, Joseph A. (2007).The Interpersonal Communication Book (Eleventh Edition). Pearson Education Inc.

Goto, A., Rima, ER, Lai, AY, Yoshida, K., Suzuki, Y., Halstead, DD, Yoshida‐Komiya, H., & Reich, MR (2014). Leveraging Public Health Nurses for Disaster Risk Communication in Fukushima City: A Qualitative Analysis of Nurses' Written Records of Parenting Counseling and Peer Discussions. BMC Health Services Research, 14, 1, 129

Kaminski, June. 2011. Diffusion of Innovation Theory. Canadian Journal of Nursing Informatics Volume 6 No. 2 2011. https://cjni.net/journal/?p=1444

Lazarus, Jeffrey V., Ratzan, Scott C., et al. 2021. A Global Survey of Potential Acceptance of a Covid-19 Vaccine. Nature Medicine Vol. 027 February 2021. https://doi.org/10.1038/s41591-020-1124-9. http://www.nature.com/naturemedicine. P 225-228

Ningrum, P. A., et al. (2020). The Potential of Poverty in the City of Palangka Raya: Study SMIs Affected Pandemic Covid 19. Budapest International Research and Critics Institute-Journal (BIRCI-Journal) Volume 3, No 3, Page: 1626-1634

Notoatmodjo,Soekidjo.2007.Kesehatan Masyarakat Ilmu dan Seni. Jakarta: Rineka Cipta

Priambodo, Nalendro. 2021. Ada 2,25 Juta Jiwa Wajib Vaksin di Kaltim, perlu 4,51 Juta Dosis Untuk Mencapai Herd Immunity. 14 Januari 2021. At https://kaltimkece.id/warta/terkini/ada-225-juta-jiwa-wajib-vaksin-di-kaltim-perlu-451-juta-dosis-untuk-capai-herd-immunity

Pujileksono, Sugeng. 2015. Metode Penelitian Komunikasi Kualitatif. Kelompok Intrans Publishing. Malang.

Rahayu, Rochani Nani., Sensusiyati. 2021. Vaksin Covid-19 di Indonesia: Analisis Berita Hoax. Intelektiva: Jurnal Ekonomi, Sosial & Humaniora E-ISSN: 2686 5661 Vol.2 No.07- February 2021

Rahmadiana. 2012. Komunikasi Kesehatan: Sebuah Tinjauan*. Jurnal Psikogenesis Vol. 1 No. 1 Desember 2021. https://core.ac.uk/download/pdf/229000618.pdf

Rogers, Everett M., 1995. Diffusion of Innovations. Fourth Edition. The Free Press New York.

Saleh, A., Mujahiddin. (2020). Challenges and Opportunities for Community Empowerment Practices in Indonesia during the Covid-19 Pandemic through Strengthening the Role of Higher Education. Budapest International Research and Critics Institute-Journal (BIRCI-Journal). Volume 3, No 2, Page: 1105-1113.

Sihombing, E. H., Nasib. (2020). The Decision of Choosing Course in the Era of Covid 19 through the Telemarketing Program, Personal Selling and College Image. Budapest International Research and Critics Institute-Journal (BIRCI-Journal) Volume 3, No. 4, Page: 2843-2850.

Wikan, Asmono. January 2021. Vaksinasi. E-Paper PR Indonesia Ed.70 Th. VI Januari 2021.

Survey Nasional. 2021. Siapa Enggan Divaksin? Tantangan dan Problematika Vaksinasi Covid-19 di Indonesia. Temuan Survey Nasional 1 – 3 Februari 2021. https://indikator.co.id/wp-content/uploads/2021/02/Materi-Rilis-Indikator-Feb_21-02-2021.pdf. Diakses pada 29 Mei 2021. Pukul 12.00 Wita.

Persepsi Masyarakat Soal vaksin Covid-19. 25 Januari 2021. https://www.wartaekonomi.co.id/read324572/4-persepsi-masyarakat-soal-vaksin-covid-19. Diakses pada 29 Mei 2021 pukul 13.00 Wita

Survey 14 Negara: Kepercayaan Vaksin Covid-19 Meningkat. 05 Maret 2021. https://www.voaindonesia.com/a/survei-14-negara-kepercayaan-vaksin-covid-19-meningkat-/5802816.html. Diakses pada 29 Mei 2021 pukul 13.30 Wita.

FAQ Seputar Pelaksanaan Vaksinasi COVID-19. https://kesmas.kemkes.go.id/assets/uploads/contents/others/FAQ_VAKSINASI_COVID__call_center.pdf. Diakses pada 03 Juli 2021.

Keputusan Direktur Jenderal Pencegahan dan Pengendalian Penyakit Nomor HK.02.02/4/1/2021 Tentang Petunjuk Teknis Pelaksanaan Vaksinasi Dalam Rangka Penanggulangan Pandemi Coronavirus Disease 2019 (COVID-19). Diakses pada 03 Juli 2021

CNN Indonesia. 19 Juli 2021. Total Vaksinasi Covid Dosis Kedua Baru Tercapai 7,82 Persen. https://www.cnnindonesia.com/nasional/20210719105047-20-669413/total-vaksinasi-covid-dosis-kedua-baru-tercapai-782-persen.

Dit. Produksi dan Distribusi Kefarmasian. 12 Januari 2021. Triple-Helix Key-Factors Menuju Sukses Vaksinasi Covid-19. https://farmalkes.kemkes.go.id/2021/01/triple-helix-key-factors-menuju-sukses-vaksinasi-covid-19/. Diakses pada 24 Juli 2021.




DOI: https://doi.org/10.33258/birci.v4i4.2963

Article Metrics

Abstract view : 3 times
PDF - 1 times

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

 

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.